{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Araliaceae", "CYP inhibition", "Hedera helix", "herb\u2013drug interaction", "human liver microsomes"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28737724", "DateCompleted": {"Year": "2018", "Month": "04", "Day": "17"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "07", "Day": "24"}], "Language": ["eng"], "ELocationID": ["1241", "10.3390/molecules22071241"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "7", "PubDate": {"Year": "2017", "Month": "Jul", "Day": "24"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine.", "Abstract": {"AbstractText": ["The extract of <i>Hedera helix L.</i> (Araliaceae), a well-known folk medicine, has been popularly used to treat respiratory problems, worldwide. It is very likely that this herbal extract is taken in combination with conventional drugs. The present study aimed to evaluate the effects of <i>H. helix</i> extract on cytochrome P450 (CYP) enzyme-mediated metabolism to predict the potential for herb-drug interactions. A cocktail probe assay was used to measure the inhibitory effect of CYP. <i>H. helix</i> extracts were incubated with pooled human liver microsomes or CYP isozymes with CYP-specific substrates, and the formation of specific metabolites was investigated to measure the inhibitory effects. <i>H. helix</i> showed significant inhibitory effects on CYP2C8, CYP2C19 and CYP2D6 in a concentration-dependent manner. In recombinant CYP2C8, CYP2C19 and CYP2D6 isozymes, the IC<sub>50</sub> values of the extract were 0.08 \u00b1 0.01, 0.58 \u00b1 0.03 and 6.72 \u00b1 0.22 mg/mL, respectively. Further investigation showed that <i>H. helix</i> extract has a positive time-dependent inhibition property on both CYP2C8 and CYP2C19 with IC<sub>50</sub> shift value of 2.77 \u00b1 0.12 and 6.31 \u00b1 0.25, respectively. Based on this in vitro investigation, consumption of herbal medicines or dietary supplements containing <i>H. helix</i> extracts requires careful attention to avoid any CYP-based interactions."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan. dr.shaheedmarwat@yahoo.com."}], "LastName": "Rehman", "ForeName": "Shaheed Ur", "Initials": "SU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. kis@hanyang.ac.kr."}], "LastName": "Kim", "ForeName": "In Sook", "Initials": "IS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. chm2456@hanyang.ac.kr."}], "LastName": "Choi", "ForeName": "Min Sun", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon 21983, Korea. kimsh11@yonsei.ac.kr."}], "LastName": "Kim", "ForeName": "Seung Hyun", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China. zhangyh@mails.tjmu.edu.cn."}], "LastName": "Zhang", "ForeName": "Yonghui", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, Korea. yoohh@hanyang.ac.kr."}], "LastName": "Yoo", "ForeName": "Hye Hyun", "Initials": "HH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "CYP2C19 protein, human"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP2C19"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP2C8"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Araliaceae"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 CYP2C19"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 CYP2C8"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hedera"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Microsomes, Liver"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Natural Medicines Comprehensive Database.  [(accessed on 2 July 2017)]; Available online:  http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=&s=ND."}, {"Citation": "Cioaca C., Margineanu C., Cucu V. The saponins of Hedera helix with antibacterial activity. Pharmazie. 1978;33:609\u2013610.", "ArticleIdList": ["733881"]}, {"Citation": "Wolf A., Gosens R., Meurs H., Haberlein H. Pre-treatment with \u03b1-hederin increases \u03b2-adrenoceptor mediated relaxation of airway smooth muscle. Phytomedicine. 2011;18:214\u2013218. doi: 10.1016/j.phymed.2010.05.010.", "ArticleIdList": ["10.1016/j.phymed.2010.05.010", "20637581"]}, {"Citation": "Stauss-Grabo M., Atiye S., Warnke A., Wedemeyer R.S., Donath F., Blume H.H. Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan\u00ae Cough Tablets) in the treatment of colds accompanied by coughing. Phytomedicine. 2011;18:433\u2013436. doi: 10.1016/j.phymed.2010.11.009.", "ArticleIdList": ["10.1016/j.phymed.2010.11.009", "21211950"]}, {"Citation": "Fazio S., Pouso J., Dolinsky D., Fernandez A., Hernandez M., Clavier G., Hecker M. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine. 2009;16:17\u201324. doi: 10.1016/j.phymed.2006.05.003.", "ArticleIdList": ["10.1016/j.phymed.2006.05.003", "16860549"]}, {"Citation": "Trute A., Gross J., Mutschler E., Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med. 1997;63:125\u2013129. doi: 10.1055/s-2006-957627.", "ArticleIdList": ["10.1055/s-2006-957627", "9140224"]}, {"Citation": "Capasso A., Pinto A., Mascolo N., Capasso F. Reduction of agonist-induced contractions of guinea-pig isolated ileum by flavonoids. Phytother. Res. 1991;5:85\u201387. doi: 10.1002/ptr.2650050210.", "ArticleIdList": ["10.1002/ptr.2650050210"]}, {"Citation": "Hegener O., Prenner L., Runkel F., Baader S.L., Kappler J., Haberlein H. Dynamics of \u03b22-adrenergic receptor\u2212ligand complexes on living cells. Biochemistry. 2004;43:6190\u20136199. doi: 10.1021/bi035928t.", "ArticleIdList": ["10.1021/bi035928t", "15147203"]}, {"Citation": "Sieben A., Prenner L., Sorkalla T., Wolf A., Jakobs D., Runkel F., Haberlein H. \u03b1-Hederin, but not hederacoside c and hederagenin from hedera helix, affects the binding behavior, dynamics, and regulation of \u03b22-adrenergic receptors. Biochemistry. 2009;48:3477\u20133482. doi: 10.1021/bi802036b.", "ArticleIdList": ["10.1021/bi802036b", "19278262"]}, {"Citation": "Rehman S.U., Choi M.S., Kim I.S., Kim S.H., Yoo H.H. An ultra-high-performance liquid chromatography-tandem mass spectrometric method for the determination of hederacoside C, a drug candidate for respiratory disorder, in rat plasma. J. Pharmaceut. Biomed. 2016;129:90\u201395. doi: 10.1016/j.jpba.2016.06.039.", "ArticleIdList": ["10.1016/j.jpba.2016.06.039", "27411171"]}, {"Citation": "Rehman S.U., Choi M.S., Choe K., Yoo H.H. Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management. Arch. Pharm. Res. 2015;37:1281\u20131298. doi: 10.1007/s12272-014-0517-z.", "ArticleIdList": ["10.1007/s12272-014-0517-z", "25475096"]}, {"Citation": "Rehman S.U., Choi M.S., Kim I.S., Luo Z., Xue Y., Yao G., Zhang Y., Yoo H.H. In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate. Molecules. 2016;21:800. doi: 10.3390/molecules21060800.", "ArticleIdList": ["10.3390/molecules21060800", "PMC6274256", "27322236"]}, {"Citation": "Arimura G.I., Maffei M. Plant Specialized Metabolism: Genomics, Biochemistry, and Biological Functions. 1st ed. CRC Press; Boca Raton, FL, USA: 2016."}, {"Citation": "Assessment report on Hedera helix, L., folium, Committee on Herbal Medicinal Products (HMPC), European Medicines Agency (EMA). EMA/HMPC/586887/2014.  [(accessed on 24 November 2015)]; Available online:  http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_HMPC_assessment_report/2016/01/WC500199887.pdf."}, {"Citation": "Liu J., Liu Y.P., Bullock P., KlaasseN C.D. Suppression of liver cytochrome P450 by \u03b1-hederin: relevance to hepatoprotection. Toxicol. Appl. Pharm. 1995;134:124\u2013131. doi: 10.1006/taap.1995.1175.", "ArticleIdList": ["10.1006/taap.1995.1175", "7676446"]}, {"Citation": "Jeong H.G. Suppression of constitutive and inducible cytochrome P450 gene expression by \u03b1-hederin in mice. IUBMB Life. 1998;46:1019\u20131026. doi: 10.1080/15216549800204572.", "ArticleIdList": ["10.1080/15216549800204572", "9861456"]}, {"Citation": "Nebert D.W., Russell D.W. Clinical importance of the cytochromes P450. Lancet. 2002;360:1155\u20131162. doi: 10.1016/S0140-6736(02)11203-7.", "ArticleIdList": ["10.1016/S0140-6736(02)11203-7", "12387968"]}, {"Citation": "Nomeir A.A., Palamanda J.R., Favreau L. Optimization in Drug Discovery: In Vitro Methods. 1st ed. Humana Press; Totowa, NJ, USA: 2004. Identification of CYP mechanism-based inhibitors; pp. 245\u2013262."}, {"Citation": "Obach R.S., Walsky R.L., Venkatakrishnan K. Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions. Drug Metab. Dispos. 2007;35:246\u2013255. doi: 10.1124/dmd.106.012633.", "ArticleIdList": ["10.1124/dmd.106.012633", "17093004"]}, {"Citation": "Riley R.J., Grime K., Weaver R. Time-dependent CYP inhibition. Expert Opin. Drug Met. 2007;3:51\u201366. doi: 10.1517/17425255.3.1.51.", "ArticleIdList": ["10.1517/17425255.3.1.51", "17269894"]}, {"Citation": "Stresser D.M., Mao J., Kenny J.R., Jones B.C., Grime K. Exploring concepts of in vitro time-dependent CYP inhibition assays. Expert Opin. Drug Met. 2014;10:157\u2013174. doi: 10.1517/17425255.2014.856882.", "ArticleIdList": ["10.1517/17425255.2014.856882", "24256452"]}, {"Citation": "Orr S.T., Ripp S.L., Ballard T.E., Henderson J.L., Scott D.O., Obach R.S., Sun H., Kalgutkar A.S. Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure\u2013activity relationships and discovery strategies to mitigate drug\u2013drug interaction risks. J. Med. Chem. 2012;55:4896\u20134933. doi: 10.1021/jm300065h.", "ArticleIdList": ["10.1021/jm300065h", "22409598"]}, {"Citation": "U.S. Food and Drug Administration (FDA), Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers.  [(accessed on 11 July 2017)]; Available online:  http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm."}, {"Citation": "Grimm S.W., Einolf H.J., Hall S.D., He K., Lim H.K., Ling K.H.J., Lu C., Nomeir A.A., Seibert E., Skordos K.W., et al. The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab. Dispos. 2009;37:1355\u20131370. doi: 10.1124/dmd.109.026716.", "ArticleIdList": ["10.1124/dmd.109.026716", "19359406"]}, {"Citation": "Rehman S.U., Choe K., Yoo H.H. Review on a traditional herbal medicine, Eurycoma longifolia jack (Tongkat Ali): its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules. 2016;21:331. doi: 10.3390/molecules21030331.", "ArticleIdList": ["10.3390/molecules21030331", "PMC6274257", "26978330"]}, {"Citation": "Kamel A., Harriman S. Inhibition of cytochrome P450 enzymes and biochemical aspects of mechanism-based inactivation (MBI). Drug Discov. Today Technol. 2013;10:e177\u2013e189. doi: 10.1016/j.ddtec.2012.09.011.", "ArticleIdList": ["10.1016/j.ddtec.2012.09.011", "24050247"]}, {"Citation": "Brahmi Z., Katho T., Hatsumata R., Hiroi A., Miyakawa N., Yakou E., Sugaya K., Onose J.I., Naoki A.B.E. Effective Cytochrome P450 (CYP) Inhibitors Isolated from Tarragon (Artemisia dracunculus) Biosci. Biotechnol. Biochem. 2012;76:1028\u20131031. doi: 10.1271/bbb.120006.", "ArticleIdList": ["10.1271/bbb.120006", "22738981"]}, {"Citation": "Taesotikul T., Dumrongsakulchai W., Wattanachai N., Navinpipat V., Somanabandhu A., Tassaneeyakul W., Tassaneeyakul W. Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Drug Metab. Pharmacokinet. 2011;26:154\u2013161. doi: 10.2133/dmpk.DMPK-10-RG-107.", "ArticleIdList": ["10.2133/dmpk.DMPK-10-RG-107", "21178301"]}, {"Citation": "Zhao Y., Hellum B.H., Liang A., Nilsen O.G. Inhibitory mechanisms of human CYPs by three alkaloids isolated from traditional chinese herbs. Phytother. Res. 2015;29:825\u2013834. doi: 10.1002/ptr.5285.", "ArticleIdList": ["10.1002/ptr.5285", "25640685"]}, {"Citation": "Han Y.M., Kim I.S., Rehman S.U., Choe K., Yoo H.H. In Vitro Evaluation of the Effects of Eurycoma longifolia Extract on CYP-Mediated Drug Metabolism. Evid. Based Complement. Alternat. Med. 2015;631329 doi: 10.1155/2015/631329.", "ArticleIdList": ["10.1155/2015/631329", "PMC4512589", "26240600"]}]}], "History": [{"Year": "2017", "Month": "6", "Day": "1"}, {"Year": "2017", "Month": "7", "Day": "17"}, {"Year": "2017", "Month": "7", "Day": "20"}, {"Year": "2017", "Month": "7", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["28737724", "PMC6152208", "10.3390/molecules22071241", "molecules22071241"]}}]}